AcuCort AB nomination committee

Being the second largest shareholder in AcuCort AB, LSIF has this week accepted an invitation to join the nomination committee. We look forward to contributing with our insight and network in the preparation of the decisions to be taken at the 2025 General Assembly at this very important time for Acucort entering the commercial phase.